Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Seaflower Ventures is a venture capital firm that specializes in early-stage investments within the life sciences, biopharmaceutical, and healthcare technology sectors. Founded in 1994 and based in Massachusetts, the firm focuses on identifying and nurturing high-potential startups developing innovative therapeutics, medical devices, and diagnostics. Seaflower typically provides seed and Series A funding, often taking an active role in management and strategic development to help portfolio companies transition from laboratory research to clinical and commercial milestones. The firm has historically targeted opportunities in the Northeast United States, leveraging its proximity to major academic and medical research hubs. As an investment firm, Seaflower does not maintain an internal drug pipeline but manages a portfolio of companies across various therapeutic areas including oncology and neurology.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Seaflower Ventures.